Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network
- PMID: 38683499
- DOI: 10.1007/s11547-024-01818-7
Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network
Abstract
Purpose: Data from recently trials have provided practice-changing recommendations in management of the axilla in early breast cancer (eBC). However, further controversies have been raised, resulting in heterogeneous diffusion of these recommendations. Our purpose was to obtain a better homogeneity.
Material and methods: In 2021, the Tuscan Breast Network (TBN) established a consensus with the aim to update recommendations in this area. We performed a literature review on axillary management in eBC patients which led to an expert Delphi consensus aiming to explore the gray areas, build consensus and propose evidence-based suggestions for an appropriate management. Thereafter, we investigate their implementation in clinical practice.
Results: (1) DCIS patients should have SLN biopsy only in case of mastectomy or in conservative surgery if tumor is in a location that would preclude future nodal sampling or in case of a mass; (2) ALND may be omitted for 1-2 positive SLN patients undergoing BCS in T1-2 tumors with 1-2 SLN positive, eligible for whole-breast irradiation and adjuvant systemic therapies; (3) consider the option of RNI in patients with 1-3 positive lymph nodes and one or more high-risk characteristics; (4) the population identified in 2) should NOT undergo lymph node irradiation as an alternative to axillary surgery and (5) patients with clinically (pre-operatively) positive axilla, or undergoing primary systemic therapy, or outside the criteria reported in 2) must receive additional ALND and/or RT as per local policy.
Conclusion: This consensus provided a practical tool to stimulate local and national breast surgical and radiotherapy protocols.
Keywords: Axillary management; Breast cancer; Breast cancer surgery; Delphi consensus; Guidelines; Positive sentinel node.
© 2024. Italian Society of Medical Radiology.
References
-
- Sávolt Á, Péley G, Polgár C, Udvarhelyi N, Rubovszky G, Kovács E et al (2017) Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla—Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer. Eur J Surg Oncol 43:672–679. https://doi.org/10.1016/j.ejso.2016.12.011 - DOI - PubMed
-
- Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR et al (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis. JAMA 318:918. https://doi.org/10.1001/jama.2017.11470 - DOI - PubMed - PMC
-
- Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJH, Mansel RE et al (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15:1303–1310. https://doi.org/10.1016/S1470-2045(14)70460-7 - DOI - PubMed - PMC
-
- Orr RK (1999) The impact of prophylactic axillary node dissection on breast cancer survival?A bayesian meta-analysis. Ann Surg Oncol 6:109–116. https://doi.org/10.1007/s10434-999-0109-1 - DOI - PubMed
-
- Krag DN, Single RM (2003) Breast cancer survival according to number of nodes removed. Ann Surg Oncol 10:1152–1159. https://doi.org/10.1245/ASO.2003.03.073 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
